Catalyst Funds Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-36,600	Closed	-$1.27M	–	1553
2024 Q2	$1.27M	Buy	36,600 +29,080	+387%	+$1.01M	0.34%	44
2024 Q1	$218K	Buy	+7,520	New	+$218K	0.06%	242